We have located links that may give you full text access.
Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal, or a General Autoimmune Comorbidity.
Thyroid : Official Journal of the American Thyroid Association 2022 December 5
BACKGROUND: The hypothalamus-pituitary-thyroid axis coordinates brain development and post-developmental function. Thyroid hormone variations, even within the normal range, have been associated with the risk of developing common psychiatric disorders, although the underlying mechanisms remain poorly understood.
METHODS: To get new insight into the potentially shared mechanisms underlying thyroid dysfunction and psychiatric disorders, we performed a comprehensive analysis of multiple phenotypic and genotypic databases. We investigated the relationship of thyroid disorders with depression, bipolar disorder, and anxiety disorders in 502,480 subjects from UK Biobank. We subsequently investigated genetic correlations between thyroid disorders, thyroid stimulating hormone (TSH) and free T4 (FT4) levels, with the genome-wide factors that predispose to psychiatric disorders. Finally, the observed global genetic correlations were furthermore pinpointed to specific local genomic regions.
RESULTS: Hypothyroidism was positively associated with an increased risk of major depressive disorder (OR=1.51, p<10⁻¹⁶) and bipolar disorder (OR=1.99, p=2.1×10⁻⁶). Genetically, strong coheritability was observed between autoimmune hypothyroidism and both major depressive (rg=0.17, p=2.7×10⁻⁴) and anxiety disorders (rg=0.17, p=6.7×10⁻⁶). This genetic correlation was particularly strong at the Major Histocompatibility Complex (MHC) locus on chromosome six (p<10⁻⁵), but further analysis showed that other parts of the genome also contributed to this global effect. Importantly, neither TSH nor FT4 levels were genetically correlated with mood disorders.
CONCLUSION: Our findings highlight an underlying association between autoimmune hypothyroidism and mood disorders, which is not mediated via thyroid hormones, and in which autoimmunity plays a prominent role. While these findings could shed new light on the potential ineffectiveness of treating (minor) variations in thyroid function in psychiatric disorders, further research is needed to identify the exact underlying molecular mechanisms.
METHODS: To get new insight into the potentially shared mechanisms underlying thyroid dysfunction and psychiatric disorders, we performed a comprehensive analysis of multiple phenotypic and genotypic databases. We investigated the relationship of thyroid disorders with depression, bipolar disorder, and anxiety disorders in 502,480 subjects from UK Biobank. We subsequently investigated genetic correlations between thyroid disorders, thyroid stimulating hormone (TSH) and free T4 (FT4) levels, with the genome-wide factors that predispose to psychiatric disorders. Finally, the observed global genetic correlations were furthermore pinpointed to specific local genomic regions.
RESULTS: Hypothyroidism was positively associated with an increased risk of major depressive disorder (OR=1.51, p<10⁻¹⁶) and bipolar disorder (OR=1.99, p=2.1×10⁻⁶). Genetically, strong coheritability was observed between autoimmune hypothyroidism and both major depressive (rg=0.17, p=2.7×10⁻⁴) and anxiety disorders (rg=0.17, p=6.7×10⁻⁶). This genetic correlation was particularly strong at the Major Histocompatibility Complex (MHC) locus on chromosome six (p<10⁻⁵), but further analysis showed that other parts of the genome also contributed to this global effect. Importantly, neither TSH nor FT4 levels were genetically correlated with mood disorders.
CONCLUSION: Our findings highlight an underlying association between autoimmune hypothyroidism and mood disorders, which is not mediated via thyroid hormones, and in which autoimmunity plays a prominent role. While these findings could shed new light on the potential ineffectiveness of treating (minor) variations in thyroid function in psychiatric disorders, further research is needed to identify the exact underlying molecular mechanisms.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app